HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil
Abstract Introduction: By the end of 2013, Brazil has implemented treatment as prevention (TasP) to every person living with HIV (PLWHA) regardless of their CD4 count, aimed at the reduction of HIV transmission. The HIV/AIDS epidemic is unevenly distributed across the territory, being concentrated i...
Guardado en:
| Formato: | Artículo |
|---|---|
| Lenguaje: | inglés |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | Ver en el sistema de origen Ver en el sistema de origen Enlace permanente (DOI o Handle) Enlace permanente (DOI o Handle) |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1881508915156353024 |
|---|---|
| collection | Producción científica |
| description | Abstract Introduction: By the end of 2013, Brazil has implemented treatment as prevention (TasP) to every person living with HIV (PLWHA) regardless of their CD4 count, aimed at the reduction of HIV transmission. The HIV/AIDS epidemic is unevenly distributed across the territory, being concentrated in capital cities and along the coast. Methodology: The following public information systems were used in this study: Laboratory Tests Control System (SISCEL), Medication Logistics Control System (SICLOM), Notifiable Diseases Information System (SINAN) and Mortality Information System (SIM). Estimations of people who were linked to both public and private HIV health care services were considered. Results: By the end of 2012, 718,000 individuals were living with HIV/AIDS (LWHA) in Brazil and it was estimated that 74% of them were linked to care, of which 313,000 were on ART. Approximately 33% (236,000) of people LWHA had viral load suppression (≤50 copies/ml) and considering those who were on ART, suppression was 76%. Remarkable regional differences in suppression were found. Whilst VL suppression among those who were on ART in the South Region was 77%, in the North Region suppression does not reach 70%. Conclusions: HIV/AIDS epidemic in Brazil follows the standard of its social disparities. The poorer the region, the lower the adherence to treatment and its effectiveness. The implementation of the new strategies in different steps of the cascade as well as the focus on regional hotspots may be the key tools to properly confront the current HIV/AIDS epidemic. Abstract O111–Figure 1 10.7448/IAS.17.2.19187 © 2014 Fábio C et al; licensee International AIDS Society Published 7 May 2014 |
| format | Article |
| id | oai:cris.upeu.edu.pe:20.500.15037/665 |
| institution | UPeU |
| language | English |
| publishDate | 2014 |
| publishDateRange | 2014 |
| publishDateSort | 2014 |
| record_format | dspace |
| spelling | oai:cris.upeu.edu.pe:20.500.15037/6652026-10-30T16:14:45ZHIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, BrazilMedicineHuman immunodeficiency virus (HIV)Antiretroviral therapyPublic healthTransmission (telecommunications)DemographyEnvironmental healthViral loadTreatment as preventionFamily medicineNursingEngineeringElectrical engineeringSociologyMedicineHuman immunodeficiency virus (HIV)Antiretroviral therapyPublic healthTransmission (telecommunications)DemographyEnvironmental healthViral loadTreatment as preventionFamily medicineNursingAnimalsAnimalsAnimalsHumansHumansHumansHIV Infections drug therapyHIV Infections drug therapyHIV Infections drug therapyAnti-HIV Agents therapeutic useAnti-HIV Agents therapeutic useAnti-HIV Agents therapeutic useHealth Sciences Medicine Infectious Diseases HIV/AIDS Research and InterventionsSocial Sciences Social Sciences Education Science and Education ResearchHealth Sciences Health Professions General Health Professions Adolescent Sexual and Reproductive HealthAbstract Introduction: By the end of 2013, Brazil has implemented treatment as prevention (TasP) to every person living with HIV (PLWHA) regardless of their CD4 count, aimed at the reduction of HIV transmission. The HIV/AIDS epidemic is unevenly distributed across the territory, being concentrated in capital cities and along the coast. Methodology: The following public information systems were used in this study: Laboratory Tests Control System (SISCEL), Medication Logistics Control System (SICLOM), Notifiable Diseases Information System (SINAN) and Mortality Information System (SIM). Estimations of people who were linked to both public and private HIV health care services were considered. Results: By the end of 2012, 718,000 individuals were living with HIV/AIDS (LWHA) in Brazil and it was estimated that 74% of them were linked to care, of which 313,000 were on ART. Approximately 33% (236,000) of people LWHA had viral load suppression (≤50 copies/ml) and considering those who were on ART, suppression was 76%. Remarkable regional differences in suppression were found. Whilst VL suppression among those who were on ART in the South Region was 77%, in the North Region suppression does not reach 70%. Conclusions: HIV/AIDS epidemic in Brazil follows the standard of its social disparities. The poorer the region, the lower the adherence to treatment and its effectiveness. The implementation of the new strategies in different steps of the cascade as well as the focus on regional hotspots may be the key tools to properly confront the current HIV/AIDS epidemic. Abstract O111–Figure 1 10.7448/IAS.17.2.19187 © 2014 Fábio C et al; licensee International AIDS Society Published 7 May 2014Articlehttps://pubmed.ncbi.nlm.nih.gov/24815847https://onlinelibrary.wiley.com/doi/pdfdirect/10.7448/IAS.17.2.19180https://doi.org/10.7448/ias.17.2.1918010.7448/ias.17.2.19180https://hdl.handle.net/20.500.15037/665W1930052698enJournal of the International AIDS Society1758-26522014-04-292026-06-13T09:30:07Z2026-06-13T09:30:07Z |
| spellingShingle | Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Engineering Electrical engineering Sociology Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Animals Animals Animals Humans Humans Humans HIV Infections drug therapy HIV Infections drug therapy HIV Infections drug therapy Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions Social Sciences Social Sciences Education Science and Education Research Health Sciences Health Professions General Health Professions Adolescent Sexual and Reproductive Health HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title | HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title_full | HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title_fullStr | HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title_full_unstemmed | HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title_short | HIV Drug Therapy in the Americas 8–10 May 2014, Rio de Janeiro, Brazil |
| title_sort | hiv drug therapy in the americas 8 10 may 2014 rio de janeiro brazil |
| topic | Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Engineering Electrical engineering Sociology Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Animals Animals Animals Humans Humans Humans HIV Infections drug therapy HIV Infections drug therapy HIV Infections drug therapy Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions Social Sciences Social Sciences Education Science and Education Research Health Sciences Health Professions General Health Professions Adolescent Sexual and Reproductive Health |
| topic_facet | Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Engineering Electrical engineering Sociology Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Public health Transmission (telecommunications) Demography Environmental health Viral load Treatment as prevention Family medicine Nursing Animals Animals Animals Humans Humans Humans HIV Infections drug therapy HIV Infections drug therapy HIV Infections drug therapy Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Anti-HIV Agents therapeutic use Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions Social Sciences Social Sciences Education Science and Education Research Health Sciences Health Professions General Health Professions Adolescent Sexual and Reproductive Health |
| url | https://pubmed.ncbi.nlm.nih.gov/24815847 https://onlinelibrary.wiley.com/doi/pdfdirect/10.7448/IAS.17.2.19180 https://doi.org/10.7448/ias.17.2.19180 https://hdl.handle.net/20.500.15037/665 |